Assembly Biosciences (ASMB) Other financing activities (2010 - 2026)

Assembly Biosciences (ASMB) posted quarterly Other financing activities of $149000.0 for Q1 2026, down 97.3% quarter-over-quarter from $5.5 million in Q3 2025.

Assembly Biosciences (ASMB) Other financing activities (2010 - 2026) Analysis & Trends

Assembly Biosciences' Other financing activities history runs 12 years deep, the most recent figure standing at $149000.0 for Q1 2026.

  • In Q1 2026, Other financing activities changed N/A year-over-year to $149000.0; the TTM figure through Mar 2026 stood at $5.7 million (up 141575.0% YoY), while the FY2025 annual figure was $5.5 million, changed N/A from the prior year.
  • Other financing activities for Q1 2026 stood at $149000.0, down from $5.5 million in the prior quarter.
  • The five-year high for Other financing activities was $5.5 million in Q3 2025, with the low at -$4000.0 in Q3 2024.
  • The 3-year median for Other financing activities is $149000.0 (2026), against an average of $1.9 million.
  • Peak annual rise in Other financing activities reached 137850.0% in 2025, while the deepest fall reached 137850.0% in 2025.
  • Assembly Biosciences' Other financing activities stood at -$4000.0 in 2024, then surged by 137850.0% to $5.5 million in 2025, then sank by 97.3% to $149000.0 in 2026.
  • Business Quant data shows ASMB's Other financing activities at $149000.0 in Q1 2026, $5.5 million in Q3 2025, and -$4000.0 in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Assembly Biosciences 670.88 Mn 350.52 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 230,000.00
Jun 30, 2026 230,000.00
Mar 31, 2026 149,000.00
Mar 31, 2026 149,000.00
Sep 30, 2025 5.51 Mn
Sep 30, 2025 5.51 Mn
Sep 30, 2024 -4,000.00
Sep 30, 2024 -4,000.00
Dec 31, 2020 22,000.00
Dec 31, 2020 22,000.00
Sep 30, 2020 843,000.00
Sep 30, 2020 843,000.00
Jun 30, 2020 483,000.00
Jun 30, 2020 483,000.00
Mar 31, 2020 119,000.00
Mar 31, 2020 119,000.00
Dec 31, 2019 2.52 Mn
Dec 31, 2019 2.52 Mn
Sep 30, 2019 1.39 Mn
Sep 30, 2019 1.39 Mn